Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
Chemosphere ; 289: 133141, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-34871614

RESUMO

This work focuses on increasing the TRL of electro-ozonizer technology by evaluating the effect of electrolyte composition and operation conditions on the production of ozone, using an actual commercial cell, CONDIAPURE®, in conditions similar to what could be expected in a real application. Not only is attention paid to the changes in the concentration of ozone in the liquid phase, but also to those observed in the gas phase. The electrolyte and its recirculation flowrate, as well as operation temperatures and pressures are found to have significant influence on production rates. The most efficient way to produce ozone is operating at low temperatures and high pressures. In this work, 0.25 and 0.21 mg O3/min were obtained operating at 10 A in electrolytes consisting of aqueous solutions of perchloric and sulfuric acid, respectively, in tests carried out at 13 °C and 2 bars of gauge pressure. The negative effect of scavengers that appear electrochemically along the production of ozone is very important and seems to be partially compensated when organics are present in the solution due to the competition between the reaction of these scavengers with ozone or organics.


Assuntos
Ozônio , Poluentes Químicos da Água , Tecnologia , Temperatura , Água , Poluentes Químicos da Água/análise
2.
Chemosphere ; 246: 125781, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-31918095

RESUMO

This work presents the development of the electrodialysis/electro-oxidation (EDEO) technology, assessing the role of the pollutant and the modelling of the system in order to look for the key aspects for the development of the technology. According to the results obtained, it can be concluded that electrodialysis can be properly used to concentrate clopyralid, having the selected ionic exchange membranes (AMX) an adsorption capacity of 1.64 ± 0.26 mg cm-2. Moreover, it was observed that BDD anodes exhibit a higher degradation and mineralization current efficiencies than MMO when using electro-oxidation (EO). The role of the supporting electrolyte was also assessed, observing a slight better performance of BDD with sulphate (maximum mineralization current efficiency of 80%) and a much superior degradation efficiency with chloride when selecting MMO as anode material. Regarding the EDEO technology, it was checked that this process only overcomes the performance of EO when using MMO anodes, a result that is explained by the ratio between degradation and transport rates. Finally, a simple model was presented and successfully used to predict the degradation rate constants and to simulate the performance of EDEO under different scenarios. These simulations confirm that the transport rate needs to overcome the degradation rate in order to assure a better performance of the EDEO system compared to the conventional EO. Moreover, the simulations explain the results obtained in the present and previous works revealing the key for a further development of the EDEO technology in the future.


Assuntos
Poluentes Ambientais , Recuperação e Remediação Ambiental/métodos , Modelos Químicos , Praguicidas , Diamante , Eletrodos , Oxirredução , Sulfatos
3.
J Environ Manage ; 248: 109289, 2019 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-31344559

RESUMO

This study deals with the development of efficient and economic electrochemical treatment processes to confront the treatment of liquid wastes containing non-polar organochlorine pesticides. In previous works, it was demonstrated that it is possible to use electrocoagulation (EC) as a concentration technique for a model organochlorine pesticide (oxyfluorfen). Within this framework, the present work describes a process for the degradation of wastes containing non-polar organochlorines (oxyfluorfen or lindane) in two consecutive stages: 1) a first stage of concentration by electrocoagulation; 2) a second stage of electrochemical degradation by electro-oxidation (EO) or electro-Fenton (EF). The first result reached in the present work is that it is possible to remove close to 50% of both pollutants using EO and more that 94% using EF. Additionally, it was proved that the addition of a pre-concentration stage decreases by a factor of 20 the power consumption needed to deplete by EO the same amount of the initial pollutant. Moreover, when EF process is performed to the concentrated stream, the power consumption is further reduced, getting values (for 1-log removal) as low as 14.51 kWh m-3 for oxyfluorfen decrease and 49.7 kWh m-3 for lindane. These results strengthen the fact that the removal efficiency increases with the concentration of the pollutant and demonstrate that the combination of concentration steps and electrochemical degradation technologies is an efficient and promising alternative for the degradation of non-polar organochlorines.


Assuntos
Hidrocarbonetos Clorados , Praguicidas , Poluentes Químicos da Água , Técnicas Eletroquímicas , Peróxido de Hidrogênio , Oxirredução
4.
Dis Markers ; 2019: 8480925, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31191757

RESUMO

PURPOSE: To analyse the capacity of whole-blood NGAL (wbNGAL) to stratify AKI in critically ill patients with and without sepsis. METHODS: Whole-blood NGAL was measured with a point-of-care device at admission and 48 hours later in patients admitted to a general ICU. Patients were classified by the AKIN and KDIGO classifications at admission and 24 and 48 hours. We performed an ROC curve analysis. wbNGAL values at admission were compared in patients with sepsis and septic shock. RESULTS: The study included 100 consecutively admitted patients (40 female) with mean age 59.1 ± 17.8 years. Thirty-three patients presented AKI at admission, and 10 more developed it in the next 48 h. Eighteen patients had AKI stage 3, 14 of them at admission. Nine patients required renal replacement therapy. According to KDIGO at admission, wbNGAL values were 78 µg/L (60-187) in stage 0 (n = 67), 263 µg/L (89-314) in stage 1 (n = 8), 484 µg/L (333-708) in stage 2 (n = 11), and 623 µg/L (231-911) in stage 3 (n = 14), p = 0.0001 for trend. Ten patients did not complete 48 hours of study: 6 of 10 were discharged (initial wbNGAL 130 µg/L (60-514)) and 4 died (773 µg/L (311-1010)). The AUROC curve of wbNGAL to predict AKI was 0.838 (95% confidence interval 0.76-0.92, p = 0.0001), with optimal cut-off value of 178 µg/L (sensitivity 76.7%, specificity 78.9%, p < 0.0001). At admission, twenty-nine patients had sepsis, of whom 20 were in septic shock. wbNGAL concentrations were 81 µg/L (60-187) in patients without sepsis, 481 (247-687) in those with sepsis, and 623.5 µg/L (361-798) in the subgroup of septic shock (p < 0.0001). CONCLUSIONS: Whole-blood NGAL concentration at ICU admission was a good stratifier of AKI in critically ill patients. However, wbNGAL concentrations were higher in septic patients irrespective of AKI occurrence.


Assuntos
Injúria Renal Aguda/sangue , Lipocalina-2/sangue , Injúria Renal Aguda/patologia , Adulto , Idoso , Biomarcadores/sangue , Estado Terminal , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
5.
Ann Intensive Care ; 7(1): 92, 2017 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-28884304

RESUMO

PURPOSE: To analyse the usefulness of the composite index of the tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) as urinary biomarkers for the early prediction of AKI in septic and non-septic patients. METHODS: This is a prospective, observational study including patients admitted to ICU from acute care departments and hospital length of stay <48 h. The main exclusion criteria were pre-existing eGFR <30 mL/min/1.73 m2 and hospitalisation 2 months prior to current admission. The [TIMP-2]·[IGFBP7] index was analysed twice, within the first 12 h of ICU admission. RESULTS: The sample included 98 patients. AKI incidence during ICU stay was 50%. Sepsis was diagnosed in 40.8%. Baseline renal variables were comparable between subgroups except for a higher baseline eGFR in non-septic patients. Patients were stratified based on the presence of AKI and their highest level of [TIMP-2]·[IGFBP7] within the first 12 h of stay. [TIMP-2]·[IGFBP7] index values were dependent on the incidence of AKI but not of sepsis. [TIMP-2]·[IGFBP7] values were significantly related to AKI severity according to AKIN criteria (p < 0.0001). The AUROC curve to predict AKI of the worst [TIMP-2]·[IGFBP7] index value was 0.798 (sensitivity 73.5%, specificity 71.4%, p < 0.0001). Index values below 0.8 ruled out any need for renal replacement (NPV 100%), whereas an index >0.8 predicted a rate of AKI of 71% and AKIN ≥ 2 of 62.9%. CONCLUSIONS: In our study, urinary [TIMP-2]·[IGFBP7] was an early predictor of AKI in ICU patients regardless of sepsis. Besides, index values <0.8(ng/mL)2/1000 ruled out the need for renal replacement.

6.
Transplant Proc ; 48(9): 3021-3023, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27932136

RESUMO

Primary graft dysfunction after heart transplantation (HTx) has a very high mortality rate, especially if the left ventricle (PGD-LV) is involved. Early diagnosis is important to select the appropriate therapy to improve prognosis. The value of high-sensitivity troponin T (HS-TNT) measurement obtained at patient arrival at the intensive care unit was analyzed in 71 HTx patients. Mild or moderate PGD-LV was defined by hemodynamic compromise with one of the following criteria: left ventricular ejection fraction <40%, hemodynamic compromise with right atrial pressure >15 mm Hg, pulmonary capillary wedge pressure >20 mm Hg, cardiac index <2.0 L/min/m2, hypotension (mean arterial pressure <70 mm Hg), and need for high-dose inotropes (inotrope score >10) or newly placed intra-aortic balloon pump. The mean recipient age was 54 ± 12 years (73% men), and donor age was 47 ± 11 years. Ischemic time was 200 ± 51 minutes, and coronary bypass time was 122 ± 31 minutes. Nine (13%) HTx patients were diagnosed with PGD-LV post-HTx, 8 with biventricular dysfunction. Four patients died, 2 with PGD-LV (22%) and 2 without PGD (4%). Mean HS-TNT before HTx was 158 ± 565 ng/L, and post-HT was 1621 ± 1269 ng/L. The area under the curve (receiver-operator characteristic) of HS-TNT to detect patients at risk of PGD-LV was 0.860 (P < .003). A cutoff value of HS-TNT >2000 ng/L had a sensitivity of 75% and specificity of 87% to identify patients at risk of PGD-LV. Multivariate analysis identified HS-TNT >2000 ng/L (P < .02) and coronary bypass-time (P < .01) as independent predictors of PGD-LV. HS-TNT >2000 ng/L at intensive care admission after HT and prolonged coronary bypass time were the most powerful predictors of PGD-LV. HS-TNT may be helpful for early detection of HTx patients at risk of PGD-LV.


Assuntos
Transplante de Coração/efeitos adversos , Disfunção Primária do Enxerto/diagnóstico , Troponina T/metabolismo , Disfunção Ventricular Esquerda/diagnóstico , Biomarcadores/metabolismo , Ponte de Artéria Coronária/efeitos adversos , Diagnóstico Precoce , Feminino , Ventrículos do Coração , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/diagnóstico , Prognóstico , Curva ROC , Sensibilidade e Especificidade , Volume Sistólico/fisiologia , Disfunção Ventricular Esquerda/etiologia
7.
Transplant Proc ; 47(8): 2395-6, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26518938

RESUMO

BACKGROUND: Endomyocardial biopsy (EMB) remains the gold standard for detecting acute rejection (AR) after heart transplantation (HTx). Non-invasive detection of AR thus far remains a challenge. Several studies have demonstrated that highly sensitive cardiac troponin T (hs-cTnT) concentrations have a low positive predictive value for diagnosing AR. Nevertheless, hs-cTnT proved to be useful for ruling out AR after HTx. An hs-cTnT concentration <17 ng/L, a value close to that used for rule-in or rule-out myocardial infarction, was associated with a 100% negative predictive value of AR. However, the cost-effectiveness of a strategy with the use of hs-cTnT for ruling out AR in HTx patients remains to be proven. METHODS: The cost-effectiveness of hs-cTnT determination for ruling out AR was assessed, comparing the costs of hs-cTnT measurements in 305 blood samples obtained at the time of EMB. Eighteen samples were excluded because the EMB was not assessable. RESULTS: Hs-cTnT determination cost 16.00€ per sample, whereas EMB cost 1752.00€ per biopsy; cost estimations included direct and indirect (30%) charges. Thirty-nine (13.6%) of the 287 blood samples presented hs-cTnT concentrations <17 ng/L; in none of them was an AR >2R degree found in the EMB. The cost of the assessment in the 287 blood samples and biopsies was of 4592.00€ for hs-cTnT and 502,824.00€ for EMB. Hs-cTnT systematic measurement would have avoided 39 EMB, with a saving of 68,328.00€, which represents the 13.5% of the total budget expended in these cases. CONCLUSIONS: The use of hs-cTnT values to rule out the need of EMB for AR diagnosis after HTx appears to be a cost-effective procedure.


Assuntos
Rejeição de Enxerto/sangue , Insuficiência Cardíaca/cirurgia , Transplante de Coração , Miocárdio/patologia , Troponina T/sangue , Adulto , Idoso , Biomarcadores/sangue , Biópsia , Análise Custo-Benefício , Feminino , Rejeição de Enxerto/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade
8.
Biochim Biophys Acta ; 1851(11): 1442-9, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26327597

RESUMO

BACKGROUND: Electronegative LDL (LDL(−)), a modified LDL fraction found in blood, induces the release of inflammatory mediators in endothelial cells and leukocytes. However, the inflammatory pathways activated by LDL(−) have not been fully defined. We aim to study whether LDL(−) induced release of the first-wave proinflammatory IL-1ß in monocytes and monocyte-derived macrophages (MDM) and the mechanisms involved. METHODS: LDL(−) was isolated from total LDL by anion exchange chromatography. Monocytes and MDM were isolated from healthy donors and stimulated with LDL(+) and LDL(−) (100 mg apoB/L). RESULTS: In monocytes, LDL(−) promoted IL-1ß release in a time-dependent manner, obtaining at 20 h-incubation the double of IL-1ß release induced by LDL(−) than by native LDL. LDL(−)-induced IL-1ß release involved activation of the CD14-TLR4 receptor complex. LDL(−) induced priming, the first step of IL-1ß release, since it increased the transcription of pro-IL-1ß (8-fold) and NLRP3 (3-fold) compared to native LDL. Several findings show that LDL(−) induced inflammasome activation, the second step necessary for IL-1ß release. Preincubation of monocytes with K+ channel inhibitors decreased LDL(−)-induced IL-1ß release. LDL(−) induced formation of the NLRP3-ASC complex. LDL(−) triggered 2-fold caspase-1 activation compared to native LDL and IL-1ß release was strongly diminished in the presence of the caspase-1 inhibitor Z-YVAD. In MDM, LDL(−) promoted IL-1ß release, which was also associated with caspase-1 activation. CONCLUSIONS: LDL(−) promotes release of biologically active IL-1ß in monocytes and MDM by induction of the two steps involved: priming and NLRP3 inflammasome activation. SIGNIFICANCE: By IL-1ß release, LDL(−) could regulate inflammation in atherosclerosis.


Assuntos
Inflamassomos/efeitos dos fármacos , Interleucina-1beta/metabolismo , Lipoproteínas LDL/farmacologia , Macrófagos/efeitos dos fármacos , Monócitos/efeitos dos fármacos , Apolipoproteína L1 , Apolipoproteínas/farmacologia , Apolipoproteínas B/farmacologia , Proteínas Adaptadoras de Sinalização CARD , Proteínas de Transporte/genética , Proteínas de Transporte/imunologia , Caspase 1/genética , Caspase 1/imunologia , Linhagem Celular , Proteínas do Citoesqueleto/genética , Proteínas do Citoesqueleto/imunologia , Regulação da Expressão Gênica , Humanos , Inflamassomos/imunologia , Interleucina-1beta/imunologia , Receptores de Lipopolissacarídeos/genética , Receptores de Lipopolissacarídeos/imunologia , Lipoproteínas HDL/farmacologia , Ativação de Macrófagos/efeitos dos fármacos , Macrófagos/citologia , Macrófagos/imunologia , Monócitos/citologia , Monócitos/imunologia , Proteína 3 que Contém Domínio de Pirina da Família NLR , Canais de Potássio/genética , Canais de Potássio/imunologia , Cultura Primária de Células , Transdução de Sinais , Eletricidade Estática , Receptor 4 Toll-Like/genética , Receptor 4 Toll-Like/imunologia , Transcrição Gênica
9.
Nutr Hosp ; 29(6): 1360-5, 2014 Jun 01.
Artigo em Espanhol | MEDLINE | ID: mdl-24972475

RESUMO

OBJECTIVE: To report the data of the Home Parenteral Nutrition (HPN) registry of the NADYA-SENPE working group for the years 2011 and 2012. METHODOLOGY: We compiled the data from the on-line registry introduced by reviewers of NADYA group responsible for monitoring of NPD introduced by since January 1, 2011 to december 31, 2012. Included fields were: age, sex, diagnosis and reason for HPN, access path, complications, beginning and end dates, complementary oral or enteral nutrition, activity level, autonomy degree, product and fungible material supply, withdrawal reason and intestinal transplant indication. RESULTS: Year 2010: 184 patients from 29 hospitals , representing a rate of 3.98 patients/million inhabitants/ year 2011, with 186 episodes were recorded NPD . During 2012, 203 patients from 29 hospitals , representing a rate of 4.39 patients/million inhabitants/year 2012 , a total of 211 episodes were recorded NPD . CONCLUSIONS: We observe an increase in registered patients with respect to previous years.Neoplasia remains as the main pathology since 2003. Although NADYA is consolidated registry and has been indispensable source of information relevant to the understanding of the progress of Home Artificial Nutrition in our country, there is ample room for improvement. Especially that refers to the registration of pediatric patients and the registration of complications.


Objetivo: Comunicar los datos del registro de Nutrición Parenteral Domiciliaria (NPD) del grupo de trabajo NADYA-SENPE de los años 2011 y 2012. Material y métodos: Recopilación de los datos del registro "on-line" introducidos por los colaboradores del grupo NADYA responsables del seguimiento de la NPD desde el 1 de enero de 2011 al 31 de diciembre de 2012 dividido por años naturales. Resultados: Año 2010: Se registraron 184 pacientes, procedentes de 29 hospitales, lo que representa una tasa de 3,98 pacientes/millón habitantes/año 2011, con 186 episodios de NPD. Durante el año 2012 se registraron 203 pacientes, procedentes de 29 hospitales, lo que representa una tasa de 4,39 pacientes/millón habitantes/año 2012, con un total de 211 episodios de NPD. Conclusiones: Se observa un aumento progresivo de los pacientes registrados respecto a años anteriores. El principal grupo patológico sigue siendo oncológico ocupando el primer lugar desde 2003. Aunque el registro NADYA es un registro consolidado y ha sido y es fuente imprescindible de información relevante para el conocimiento de los avances de la Nutrición Artificial Domiciliaria en nuestro país, queda un amplio margen para la mejora. En especial lo que hace referencia al registro de pacientes pediátricos y al registro de las complicaciones.


Assuntos
Nutrição Parenteral no Domicílio/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/epidemiologia , Neoplasias/terapia , Soluções de Nutrição Parenteral , Nutrição Parenteral no Domicílio/efeitos adversos , Sistema de Registros , Espanha/epidemiologia , Adulto Jovem
10.
Rev. chil. nutr ; 39(4): 129-134, dic. 2012. ilus
Artigo em Espanhol | LILACS | ID: lil-673059

RESUMO

Antecedentes. La televisión es un medio de comunicación que desarrolla la cultura, entretenimiento, costumbres y hábitos en un ambiente sedentario, por lo que su consecuencia en la salud nutricional debe estudiarse. Objetivo. Correlacionar el tiempo destinado a ver TV con el estado nutricional y los hábitos alimentarios ninos entre 3 y 6 anos. Metodología. Estudio de corte transversal a 45 menores de edad residentes en la población Jardín del Este, en la ciudad de Talca (Chile), abordados mediante visita domiciliaria. Se evaluó el estado nutricional, aplicó una encuesta de tendencia de consumo y se registró el tiempo en ver televisión en casa/día. Los resultados se analizaron con Stata 10,1. Resultados. El 73,3% de los ninos ven televisión entre 4 y 7 horas diarias. El tiempo destinado para televisión fue de 3,5 ± 1,0 horas en eutróficos, 4,7 ± 0.9 horas en ninos con sobrepeso y 5,6 ± 0,9 horas en o besos (p<0,001). Ninos que consumen más porciones al día de azúcares pasan en promedio más horas de TV (p<0,05). Conclusión. El tiempo destinado a la televisión en casa influye en el estado nutricional y en los hábitos alimentarios de los ninos.


Background: Television (TV) is a medium that massively delivers entertainment, information and culture in Chilean society contributing to create sedentary habits in children. Objective: To associate the time dedicated to TV watching with nutritional status and food habits in 3 to 6 years old children. Design: A cross-sectional study of 45 children residents of the population "Jardín del Este" in Talca was performed through home visits. Nutritional status was assessed and the time spent watching TV was recorded. Data was analyzed using Stata 10.1. Results: The majority (73.3%) of children watched TV between 4 and 7 hours daily. The time devoted to watching TV was 3.47 ± 1.0 hours in eutrofic children, 4.7 ± 0.9 hours in overweight and 5.6 ± 0.9 hours in obese (p<0.05). Children who consumed more servings of sugar daily spent on average more hours watching TV (p<0,05). Conclusions: The time dedicated to watch TV at home influences the nutritional status and dietary habits of children.


Assuntos
Criança , Televisão , Exercício Físico , Criança , Estado Nutricional , Comportamento Alimentar , Chile
11.
Nutr Hosp ; 27(1): 205-8, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-22566322

RESUMO

INTRODUCTION: Autologous bone marrow transplant (ABMT) represents a high metabolic stress. Glutamine has proven to be effective in severe catabolic states, although there are controversial studies. OBJECTIVES: To assess the effect of parenteral nutrition (PN) therapy supplemented with glutamine on the occurrence of mucositis and mean hospital stay in patients submitted to ABMT. METHODS: Retrospective study of patients submitted to ABMT between 2006 and 2009. In 2008, one vial of L-alanyl-L-glutamine (20 g) was added by protocol to the PN formulations of these patients. Thirteen clinical charts since that date (glutamine group) and 13 previous charts (control group) were randomly selected (n = 26). We compared the degree of mucositis and hospital stay in both groups. In the subgroup of glutamine-treated patients, we compare the glutamine dose in the patients developing some degree of mucositis with that of those not having this complication. RESULTS: Mean hospital stay: 27.8 ± 7.4 days (control group) vs. 20.3 ± 5.3 days (glutamine group) (p = 0.01). The severity of mucositis was lower in the glutaminetreated group (p = 0.02). The weight-adjusted dose of L-alanyl-L-glutamine in the patients not developing mucositis was higher than in the other ones (0.32 vs. 0.24 g/kg/day; p = 0.02). CONCLUSIONS: Glutamine supplementation reduces the degree of mucositis and hospital stay in patients submitted to autologous bone marrow transplantation. The degree of mucositis is lower in the subgroup of patients receiving higher doses of glutamine.


Assuntos
Transplante de Medula Óssea/métodos , Glutamina/uso terapêutico , Nutrição Parenteral/métodos , Adulto , Transplante de Medula Óssea/efeitos adversos , Dipeptídeos/administração & dosagem , Dipeptídeos/uso terapêutico , Feminino , Glutamina/administração & dosagem , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Mucosite/epidemiologia , Mucosite/etiologia , Mucosite/prevenção & controle , Estudos Retrospectivos
12.
Gynecol Endocrinol ; 28(4): 264-8, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21962027

RESUMO

Polycystic ovary syndrome (PCOS) is associated with the metabolic syndrome (MetS). The metabolic disorders are not universal and may vary with race, age and phenotype. Our purpose was to determine the clinical and biochemical characteristics of Mediterranean PCOS women with MetS, compare them with non-MetS PCOS patients, and assess the ability of clinical data and biochemical tests to predict these abnormalities within our population. A total of 218 subjects, 196 PCOS women and 22 controls, undergo a physical examination and laboratory evaluation for a diagnosis of MetS. MetS was categorized according to NCEP ATP III guidelines. PCOS patients were analyzed separately and compared in three subgroups: three or more MetS criteria, two criteria, one or no criteria. The overall prevalence of MetS was 21.4%. Women with MetS had higher glucose (G) levels than PCOS women with two criteria (5.7 ± 1.5 vs 5 ± 0.4, p < 0.05). Both groups were comparable for all the other parameters. Waist circumference (WC), body mass index (BMI), systolic (SBP) and diastolic blood pressure (DBP), bioavailable testosterone (uT), triglycerides (TG) and insulin (I) levels were significantly higher and sex hormone-binding globulin (SHBG) levels, high-density lipoprotein (HDL), HOMA and QUICKI indexes significantly lower in both groups, MetS and patients with two criteria, compared with women with one or no criteria and the control group. WC, HDL and TG were the best predictors of PCOS patients at risk for MetS. In conclusion, we recommend considering PCOS patients with two criteria of MetS as having the same risk as patients with the full syndrome. Waist circumference with HDL and triglycerides is an efficient combined test to identify PCOS women at risk for metabolic and cardiovascular diseases.


Assuntos
Glicemia , Síndrome Metabólica/complicações , Obesidade/complicações , Síndrome do Ovário Policístico/complicações , Adulto , Índice de Massa Corporal , Feminino , Humanos , Lipoproteínas HDL/sangue , Síndrome Metabólica/sangue , Síndrome Metabólica/epidemiologia , Obesidade/sangue , Síndrome do Ovário Policístico/sangue , Prevalência , Fatores de Risco , Triglicerídeos/sangue , Circunferência da Cintura , Mulheres , Adulto Jovem
13.
Obes Surg ; 18(4): 408-14, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18264836

RESUMO

BACKGROUND: Abdominal fat (both visceral and subcutaneous) accumulation is associated with an increased risk of developing insulin resistance. The latter stands as the basis upon which diabetes, hypertension, and atherogenic dyslipidemia tend to build up. Hence, abdominal liposuction (AL) could theoretically hold metabolic benefits. We undertook the present study to assess the effects of AL on carbohydrate and lipid metabolism. METHODS: This is a prospective study including 20 healthy volunteers (M2/F18) aged 39.6 +/- 7.7 years old (24-52), body mass index (BMI) = 25.3 +/- 4.7 kg/m(2) (19.8-36) who underwent AL. Before and 4 months after AL, we measured glucose and insulin concentrations, HOMA index [glucose (mM) x IRI (microUI/l)/22.5], free fatty acids (FFA), glycerol, total cholesterol and triglycerides, high-density lipoprotein (HDL)-cholesterol (HDL-c), low-density lipoprotein (LDL)-cholesterol (LDL-c), very low-density lipoprotein (VLDL)-cholesterol (VLDL-c) and apolipoproteins (apo) B, AI and AII, adiponectin (Adp), and ultra-sensitive C-reactive protein (CRP). RESULTS: Lipo-aspirate averaged 5.494 +/- 5.297 cc (600-19.000). Weight, BMI, and waist circumference decreased significantly 4 months after surgery by 4.6, 4.6 and 5.9%, respectively. There were significant decrements in FFA (-35%, p < 0.0001), glycerol (-63%, p < 0.0005), VLDL-c (-15.2%; p < 0.001), and triglycerides (-21.3%, p < 0.002), an increase in HDL-c (+10%, p < 0.03), Apo AI (+10.1%, p < 0.02), and Apo AII (+11.8%, p < 0.001). Total cholesterol, LDL-c, ApoB, and the LDL-c/ApoB ratio raised by +15% (p < 0.0005), +27.3% (p < 0.000), +15.1% (p < 0.008) and +2.76% (p < 0.008), respectively. Glucose, insulin, the HOMA index, Adp, and CRP were not significantly altered after AL. CONCLUSION: AL in healthy normal weight or slightly overweight subjects improves the major lipoprotein components of obesity-associated dyslipidemia. This improvement occurs independent of insulin sensitivity.


Assuntos
Resistência à Insulina/fisiologia , Lipectomia , Metabolismo dos Lipídeos/fisiologia , Sobrepeso/metabolismo , Sobrepeso/cirurgia , Gordura Subcutânea Abdominal/cirurgia , Adiponectina/sangue , Adulto , Glicemia/metabolismo , Proteína C-Reativa/metabolismo , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
14.
J. venom. anim. toxins incl. trop. dis ; 13(4): 881-884, 2007. tab
Artigo em Inglês | LILACS | ID: lil-471148

RESUMO

Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality in solid organ transplantation. Disseminated toxoplasmosis after liver transplantation is a rare but fatal event. Serologic screening of the donor and the recipient is essential to prophylactic management, early diagnosis and therapeutic strategies to minimize the consequences of these infections. The aim of the present study was to determine the seroprevalence of CMV and Toxoplasma gondii (TG) in a Brazilian liver transplant waiting list (LTWL). Serological data were collected from 44 candidates on the LTWL between May 2003 and November 2004. Serological investigation of antibodies IgM and IgG against CMV (anti-CMV) and TG (anti-T. gondii) was performed using fluorometry commercial kits. IgG anti-CMV was positive in 37 patients (94.9 percent) out of 39 available results. There were not IgM anti-CMV positive results. Out of 36 analyzed patients, 22 (61.1 percent) presented positive IgG anti-T. gondii and none had positive IgM anti-T. gondii. The high CMV seroprevalence among our LTWL reinforces the need for appropriate protocols to avoid related complications, like reactivation and superinfection by CMV. Environmental and drug prophylactic strategies against primary infection and reactivation, as well as early diagnosis and treatment of toxoplasmosis complications, are essential for the good outcome of transplant patients.


Assuntos
Humanos , Masculino , Feminino , Brasil , Infecções por Citomegalovirus/epidemiologia , Transplante de Fígado , Estudos Soroepidemiológicos , Toxoplasmose , Listas de Espera
15.
Prensa méd. argent ; 93(3): 187-190, 2006.
Artigo em Espanhol | LILACS | ID: lil-471571

RESUMO

El objetivo de este trabajo es analizar los primeros 71 casos de Histerectomía Laparoscópica (HTL) y Anexohisterectomía Laparoscópica (AHTL) realizados en el Servicio de Ginecología de Clínica Güemes de Luján


Assuntos
Feminino , Adulto , Humanos , Endometriose , Histerectomia , Histerectomia Vaginal , Laparoscopia , Menorragia , Incontinência Urinária por Estresse
16.
Res Microbiol ; 152(10): 901-5, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11766965

RESUMO

Superoxide dismutases (SODs) are vital components that defend against oxidative stress through decomposition of superoxide radical. Escherichia coli contains two highly homologous SODs, a manganese- and an iron-containing enzyme (Mn-SOD and Fe-SOD, respectively). In contrast, a single Mn-SOD is present in Bacillus subtilis. In E. coli, the absence of SODs was found to be associated with an increased sensitivity to cadmium, nickel and cobalt ions. Mutants lacking either sodA or sodB exhibited metal resistance to levels comparable to that of the wild-type strain. Although sod-deficient mutant cells were more resistant to zinc than their wild-type counterpart, no differences between the strains were observed in the presence of copper. In B. subtilis, the sodA mutation had no effect on cadmium and copper resistance. These results suggest that intracellular generation of superoxide by cadmium, nickel and cobalt is toxic in E. coli. They support the participation of sod genes in its protection against metal stress.


Assuntos
Proteínas de Bactérias/fisiologia , Escherichia coli/efeitos dos fármacos , Metais Pesados/farmacologia , Superóxido Dismutase/fisiologia , Proteínas de Bactérias/genética , Cádmio/farmacologia , Cátions , Cobalto/farmacologia , Escherichia coli/enzimologia , Testes de Sensibilidade Microbiana , Mutação , Níquel/farmacologia , Superóxido Dismutase/genética
17.
Arterioscler Thromb Vasc Biol ; 20(10): 2281-7, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11031216

RESUMO

The presence in plasma of an electronegative LDL subfraction [LDL(-)] cytotoxic for endothelial cells (ECs) has been reported. We studied the effect of LDL(-) on the release by ECs of molecules implicated in leukocyte recruitment [interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1)] and in the plasminogen activator inhibitor-1 (PAI-1). LDL(-), isolated by anion-exchange chromatography, differed from nonelectronegative LDL [LDL(+)] in its higher triglyceride, nonesterified fatty acid, apoprotein E and apoprotein C-III, and sialic acid contents. No evidence of extensive oxidation was found in LDL(-); its antioxidant and thiobarbituric acid-reactive substances contents were similar to those of LDL(+). However, conjugated dienes were increased in LDL(-), which suggests that mild oxidation might affect these particles. LDL(-) increased, in a concentration-dependent manner, the release of IL-8 and MCP-1 by ECs and was a stronger inductor of both chemokines than oxidized LDL (oxLDL) or LDL(+). PAI-1 release increased slightly in ECs incubated with both LDL(-) and oxLDL but not with LDL(+). However, no cytotoxic effects of LDL(-) were observed on ECs. Actinomycin D inhibited the release of IL-8 and MCP-1 induced by LDL(-) and oxLDL by up to 80%, indicating that their production is mediated by protein synthesis. Incubation of ECs with N:-acetyl cysteine inhibited production of IL-8 and MCP-1 induced by LDL(-) and oxLDL by >50%. The free radical scavenger butylated hydroxytoluene slightly inhibited the effect of oxLDL but did not modify the effect of LDL(-). An antagonist (BN-50730) of the platelet-activating factor receptor inhibited production of both chemokines by LDL(-) and oxLDL in a concentration-dependent manner. Our results indicate that LDL(-) shows proinflammatory activity on ECs and may contribute to early atherosclerotic events.


Assuntos
Quimiocina CCL2/biossíntese , Endotélio Vascular/efeitos dos fármacos , Interleucina-8/biossíntese , Lipoproteínas LDL/farmacologia , Acetilcisteína/farmacologia , Adulto , Antioxidantes , Células Cultivadas , Cromatografia por Troca Iônica , Dactinomicina/farmacologia , Relação Dose-Resposta a Droga , Eletroforese em Gel de Poliacrilamida , Endotélio Vascular/metabolismo , Feminino , Sequestradores de Radicais Livres/farmacologia , Humanos , Lipoproteínas LDL/antagonistas & inibidores , Lipoproteínas LDL/química , Masculino , Pessoa de Meia-Idade , Inibidor 1 de Ativador de Plasminogênio/biossíntese , Tiobarbitúricos , Fator de Necrose Tumoral alfa/farmacologia
18.
Curr Microbiol ; 41(3): 201-5, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10915208

RESUMO

Thirty thermophilic strains isolated from heavy metal-rich hydrothermal vent sites at Lau Basin were tested for their susceptibility to cadmium, zinc, cobalt, and nickel. The 14 aerobic spore formers belonging to the genus Bacillus, 6 anaerobic fermenters from the order Thermotogales, and 10 anaerobic sulfur reducers from the order Thermococcales could be clearly distinguished according to their metal susceptibilities. The Thermococcales were found to exhibit the highest resistance to cadmium and zinc, whereas Thermotogales were highly sensitive to these metals. In contrast, the Thermotogales displayed the highest resistance to cobalt ions. No clear distinction could be established between the metal susceptibilities of these strains and seven reference organisms used for comparative studies. Cadmium resistance, slightly inducible in some cadmium-resistant bacilli, was not plasmid mediated. The amount of cadmium immobilized by the Thermotogales was related to their level of resistance to this metal.


Assuntos
Bacillus/efeitos dos fármacos , Bactérias Anaeróbias/efeitos dos fármacos , Metais Pesados/farmacologia , Thermococcales/efeitos dos fármacos , Microbiologia da Água , Bacillus/crescimento & desenvolvimento , Bactérias Anaeróbias/metabolismo , Cádmio/análise , Cádmio/farmacologia , Cobalto/farmacologia , Meios de Cultura , Resistência Microbiana a Medicamentos , Concentração de Íons de Hidrogênio , Metais Pesados/análise , Testes de Sensibilidade Microbiana , Oceano Pacífico , Fatores de Tempo , Zinco/farmacologia
19.
J Mol Med (Berl) ; 78(3): 147-54, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10868477

RESUMO

Hyperhomocyst(e)inemia is an independent risk factor for atherothrombosis in several clinical settings in which renal function is impaired, but its prevalence in the nephrotic syndrome has not been investigated in detail, even though this syndrome provides an excellent model in which to study a possible link between albuminuria, proteinuria, and hyperhomocyst(e)inemia. We obtained plasma and urine from 27 patients with biopsy-confirmed membranous glomerulonephritis presenting nephrotic syndrome and 27 matched controls and determined the concentrations of homocyst(e)ine and proteins considered putative markers of glomerular and tubular function. Hyperhomocyst(e)inemia, defined as the mean +SD of the plasma homocyst(e)ine concentration of the controls [plasma homocyst(e)ine concentration >10.8 micromol/l] was present in 26% of the patients with nephrotic syndrome but in only 7.4% of the controls. Furthermore, the degree of hyperhomocyst(e)inemia was more severe in the nephrotic patients than in the controls. The existence of renal failure, tubular damage, and, interestingly, relatively well conserved glomerular function barrier were the main predictors of increased levels of plasma homocyst(e)ine. In conclusion, hyperhomocyst(e)inemia is a frequent cardiovascular risk factor present in patients with nephrotic syndrome and renal failure, but it is not directly associated with proteinuria.


Assuntos
Homocisteína/sangue , Síndrome Nefrótica/sangue , Adulto , Albuminúria/sangue , Estudos de Casos e Controles , Creatina/metabolismo , Diabetes Mellitus/sangue , Diabetes Mellitus/urina , Feminino , Homocisteína/urina , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Síndrome Nefrótica/urina , Proteinúria/sangue , Fatores de Risco
20.
Am J Cardiol ; 84(6): 655-9, 1999 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-10498134

RESUMO

Most described modifications of low-density lipoprotein (LDL) cholesterol share an increase in its negative electric charge; in fact, an electronegative form of LDL can be identified and isolated from plasma. Although the exact nature of the chemical modification of electronegative LDL is still controversial, its toxicity on endothelial cells has been demonstrated. Statins have protective effects against cardiovascular disease that are independent of their lipid-lowering action and which could be due, at least in part, to the prevention of LDL modification. We evaluated the effect of 6 months of simvastatin therapy (40 mg/day) on electronegative LDL proportion and LDL susceptibility to in vitro induced oxidation in 21 patients with heterozygous familial hypercholesterolemia (FH). Eleven normolipemic subjects were analyzed as a control group. Total cholesterol as well as LDL and very low density lipoprotein cholesterol, triglycerides, and apoprotein B decreased 30% after the first month of therapy, with no further decreases thereafter. LDL susceptibility to oxidation was similar in FH patients and controls and did not change throughout the treatment. Electronegative LDL proportion was 35.1 +/- 9.9% in FH patients and 9.1 +/- 2.4% in control subjects (p <0.0001) but, in contrast to total LDL cholesterol and the rest of lipid parameters, it decreased to 28.6 +/- 9.1% in the third month and to 21.2 +/- 7.7% in the sixth month of therapy. The decrease in these cytotoxic particles may be a relevant mechanism by which simvastatin protects against cardiovascular disease.


Assuntos
Anticolesterolemiantes/uso terapêutico , LDL-Colesterol/sangue , Heterozigoto , Hiperlipoproteinemia Tipo II/tratamento farmacológico , Sinvastatina/uso terapêutico , Adulto , Anticolesterolemiantes/efeitos adversos , Apolipoproteínas B/sangue , Colesterol/sangue , VLDL-Colesterol/sangue , Aberrações Cromossômicas/genética , Transtornos Cromossômicos , Feminino , Seguimentos , Genes Dominantes/genética , Humanos , Hiperlipoproteinemia Tipo II/sangue , Hiperlipoproteinemia Tipo II/genética , Masculino , Pessoa de Meia-Idade , Sinvastatina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA